Long-term real world clinical outcomes of macitentan therapy in chronic thromboembolic pulmonary hypertension

BackgroundMacitentan treatment for chronic thromboembolic pulmonary hypertension (CTEPH) in the routine clinical setting is increasing. However, ‘real world’ macitentan experience is scarce and is needed to differentiate from controlled clinical trial settings.ObjectiveWe describe our outcomes and clinical ‘real world’ experience of macitentan mono- and combination therapy with riociguat or sildenafil in CTEPH.MethodsWe included all consecutive...